Ciprofibrate



Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 13.7%
Hiv Infection 11.8%
Hyperlipidaemia 9.8%
Blood Cholesterol Increased 8.8%
Depression 8.8%
Prophylaxis 6.9%
Type 2 Diabetes Mellitus 6.9%
Onychomycosis 5.9%
Dyslipidaemia 4.9%
Hypersensitivity 3.9%
Ulcer 3.9%
Blood Pressure Abnormal 2.9%
Blood Triglycerides Increased 2.0%
Drug Use For Unknown Indication 2.0%
Hepatitis B 2.0%
Osteoarthritis 2.0%
Arrhythmia 1.0%
Blood Triglycerides Abnormal 1.0%
Blood Uric Acid Abnormal 1.0%
Dysuria 1.0%
Eye Swelling 16.0%
Pancreatitis Necrotising 16.0%
Myalgia 8.0%
Tachypnoea 8.0%
Blood Cholesterol Increased 4.0%
Dengue Fever 4.0%
Disorientation 4.0%
Dysentery 4.0%
Hepatic Failure 4.0%
Hyperkalaemia 4.0%
Pancreatitis Acute 4.0%
Prothrombin Time Prolonged 4.0%
Swelling Face 4.0%
Toxic Epidermal Necrolysis 4.0%
Toxicity To Various Agents 4.0%
Vomiting 4.0%
Weight Increased 4.0%
Concomitant
Hypertension 20.2%
Product Used For Unknown Indication 14.8%
Diabetes Mellitus 10.2%
Hiv Infection 6.6%
Type 2 Diabetes Mellitus 6.6%
Drug Use For Unknown Indication 6.0%
Rheumatoid Arthritis 4.8%
Blood Cholesterol Increased 3.2%
Depression 2.9%
Neoplasm Malignant 2.9%
Blood Cholesterol 2.8%
Hypercholesterolaemia 2.8%
Unevaluable Event 2.6%
Dyslipidaemia 2.2%
Cardiac Disorder 2.0%
Prostate Cancer 2.0%
Blood Triglycerides Increased 1.9%
Osteoporosis 1.9%
Prophylaxis 1.9%
Chronic Lymphocytic Leukaemia 1.7%
Weight Decreased 11.3%
Weight Increased 10.0%
Sepsis 7.5%
Anal Abscess 6.3%
Death 5.0%
Hypertension 5.0%
Septic Shock 5.0%
Vomiting 5.0%
Wheezing 5.0%
Wound 5.0%
Dyspnoea 3.8%
Heart Rate Decreased 3.8%
Nausea 3.8%
Off Label Use 3.8%
Pelvic Fracture 3.8%
Pseudomyxoma Peritonei 3.8%
Tendon Rupture 3.8%
Urticaria 3.8%
Blood Glucose Increased 2.5%
Cardiac Arrest 2.5%
Interacting
Pain In Extremity 38.9%
Hyperlipidaemia 22.2%
Hypercholesterolaemia 16.7%
Tendon Pain 11.1%
Type Iii Hyperlipidaemia 11.1%
Rhabdomyolysis 100.0%